Report Detail

Request for Sample of this report

Pharma & Healthcare Global Nicotinamide Riboside Supplements Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4561720
    • |
  • 21 October, 2023
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Nicotinamide Riboside Supplements market size was valued at USD 69 million in 2022 and is forecast to a readjusted size of USD 109.9 million by 2029 with a CAGR of 6.9% during review period.
The Global Info Research report includes an overview of the development of the Nicotinamide Riboside Supplements industry chain, the market status of Online Sales (Capsule, Liquid), Offline Sales (Capsule, Liquid), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nicotinamide Riboside Supplements.
Regionally, the report analyzes the Nicotinamide Riboside Supplements markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nicotinamide Riboside Supplements market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nicotinamide Riboside Supplements market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nicotinamide Riboside Supplements industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Capsule, Liquid).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nicotinamide Riboside Supplements market.
Regional Analysis: The report involves examining the Nicotinamide Riboside Supplements market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nicotinamide Riboside Supplements market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nicotinamide Riboside Supplements:
Company Analysis: Report covers individual Nicotinamide Riboside Supplements manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nicotinamide Riboside Supplements This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Online Sales, Offline Sales).
Technology Analysis: Report covers specific technologies relevant to Nicotinamide Riboside Supplements. It assesses the current state, advancements, and potential future developments in Nicotinamide Riboside Supplements areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nicotinamide Riboside Supplements market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nicotinamide Riboside Supplements market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Capsule
Liquid
Softgel
Market segment by Application
Online Sales
Offline Sales
Major players covered
Thorne
Codeage
ProHealth Longevity
ChromaDex
HPN Nutraceuticals
Cytoplan
solodate
Orgabay
Rossylla
Life Extension
Aesticum
ProHealth
NOW
Double Wood Supplements
aSquared Nutrition
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinamide Riboside Supplements product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nicotinamide Riboside Supplements, with price, sales, revenue and global market share of Nicotinamide Riboside Supplements from 2018 to 2023.
Chapter 3, the Nicotinamide Riboside Supplements competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide Riboside Supplements breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nicotinamide Riboside Supplements market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotinamide Riboside Supplements.
Chapter 14 and 15, to describe Nicotinamide Riboside Supplements sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Nicotinamide Riboside Supplements
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nicotinamide Riboside Supplements Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Capsule
    • 1.3.3 Liquid
    • 1.3.4 Softgel
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nicotinamide Riboside Supplements Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Online Sales
    • 1.4.3 Offline Sales
  • 1.5 Global Nicotinamide Riboside Supplements Market Size & Forecast
    • 1.5.1 Global Nicotinamide Riboside Supplements Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Nicotinamide Riboside Supplements Sales Quantity (2018-2029)
    • 1.5.3 Global Nicotinamide Riboside Supplements Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Thorne
    • 2.1.1 Thorne Details
    • 2.1.2 Thorne Major Business
    • 2.1.3 Thorne Nicotinamide Riboside Supplements Product and Services
    • 2.1.4 Thorne Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Thorne Recent Developments/Updates
  • 2.2 Codeage
    • 2.2.1 Codeage Details
    • 2.2.2 Codeage Major Business
    • 2.2.3 Codeage Nicotinamide Riboside Supplements Product and Services
    • 2.2.4 Codeage Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Codeage Recent Developments/Updates
  • 2.3 ProHealth Longevity
    • 2.3.1 ProHealth Longevity Details
    • 2.3.2 ProHealth Longevity Major Business
    • 2.3.3 ProHealth Longevity Nicotinamide Riboside Supplements Product and Services
    • 2.3.4 ProHealth Longevity Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 ProHealth Longevity Recent Developments/Updates
  • 2.4 ChromaDex
    • 2.4.1 ChromaDex Details
    • 2.4.2 ChromaDex Major Business
    • 2.4.3 ChromaDex Nicotinamide Riboside Supplements Product and Services
    • 2.4.4 ChromaDex Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 ChromaDex Recent Developments/Updates
  • 2.5 HPN Nutraceuticals
    • 2.5.1 HPN Nutraceuticals Details
    • 2.5.2 HPN Nutraceuticals Major Business
    • 2.5.3 HPN Nutraceuticals Nicotinamide Riboside Supplements Product and Services
    • 2.5.4 HPN Nutraceuticals Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 HPN Nutraceuticals Recent Developments/Updates
  • 2.6 Cytoplan
    • 2.6.1 Cytoplan Details
    • 2.6.2 Cytoplan Major Business
    • 2.6.3 Cytoplan Nicotinamide Riboside Supplements Product and Services
    • 2.6.4 Cytoplan Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Cytoplan Recent Developments/Updates
  • 2.7 solodate
    • 2.7.1 solodate Details
    • 2.7.2 solodate Major Business
    • 2.7.3 solodate Nicotinamide Riboside Supplements Product and Services
    • 2.7.4 solodate Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 solodate Recent Developments/Updates
  • 2.8 Orgabay
    • 2.8.1 Orgabay Details
    • 2.8.2 Orgabay Major Business
    • 2.8.3 Orgabay Nicotinamide Riboside Supplements Product and Services
    • 2.8.4 Orgabay Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Orgabay Recent Developments/Updates
  • 2.9 Rossylla
    • 2.9.1 Rossylla Details
    • 2.9.2 Rossylla Major Business
    • 2.9.3 Rossylla Nicotinamide Riboside Supplements Product and Services
    • 2.9.4 Rossylla Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Rossylla Recent Developments/Updates
  • 2.10 Life Extension
    • 2.10.1 Life Extension Details
    • 2.10.2 Life Extension Major Business
    • 2.10.3 Life Extension Nicotinamide Riboside Supplements Product and Services
    • 2.10.4 Life Extension Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Life Extension Recent Developments/Updates
  • 2.11 Aesticum
    • 2.11.1 Aesticum Details
    • 2.11.2 Aesticum Major Business
    • 2.11.3 Aesticum Nicotinamide Riboside Supplements Product and Services
    • 2.11.4 Aesticum Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Aesticum Recent Developments/Updates
  • 2.12 ProHealth
    • 2.12.1 ProHealth Details
    • 2.12.2 ProHealth Major Business
    • 2.12.3 ProHealth Nicotinamide Riboside Supplements Product and Services
    • 2.12.4 ProHealth Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 ProHealth Recent Developments/Updates
  • 2.13 NOW
    • 2.13.1 NOW Details
    • 2.13.2 NOW Major Business
    • 2.13.3 NOW Nicotinamide Riboside Supplements Product and Services
    • 2.13.4 NOW Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 NOW Recent Developments/Updates
  • 2.14 Double Wood Supplements
    • 2.14.1 Double Wood Supplements Details
    • 2.14.2 Double Wood Supplements Major Business
    • 2.14.3 Double Wood Supplements Nicotinamide Riboside Supplements Product and Services
    • 2.14.4 Double Wood Supplements Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Double Wood Supplements Recent Developments/Updates
  • 2.15 aSquared Nutrition
    • 2.15.1 aSquared Nutrition Details
    • 2.15.2 aSquared Nutrition Major Business
    • 2.15.3 aSquared Nutrition Nicotinamide Riboside Supplements Product and Services
    • 2.15.4 aSquared Nutrition Nicotinamide Riboside Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 aSquared Nutrition Recent Developments/Updates

3 Competitive Environment: Nicotinamide Riboside Supplements by Manufacturer

  • 3.1 Global Nicotinamide Riboside Supplements Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Nicotinamide Riboside Supplements Revenue by Manufacturer (2018-2023)
  • 3.3 Global Nicotinamide Riboside Supplements Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Nicotinamide Riboside Supplements by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Nicotinamide Riboside Supplements Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Nicotinamide Riboside Supplements Manufacturer Market Share in 2022
  • 3.5 Nicotinamide Riboside Supplements Market: Overall Company Footprint Analysis
    • 3.5.1 Nicotinamide Riboside Supplements Market: Region Footprint
    • 3.5.2 Nicotinamide Riboside Supplements Market: Company Product Type Footprint
    • 3.5.3 Nicotinamide Riboside Supplements Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nicotinamide Riboside Supplements Market Size by Region
    • 4.1.1 Global Nicotinamide Riboside Supplements Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Nicotinamide Riboside Supplements Consumption Value by Region (2018-2029)
    • 4.1.3 Global Nicotinamide Riboside Supplements Average Price by Region (2018-2029)
  • 4.2 North America Nicotinamide Riboside Supplements Consumption Value (2018-2029)
  • 4.3 Europe Nicotinamide Riboside Supplements Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Nicotinamide Riboside Supplements Consumption Value (2018-2029)
  • 4.5 South America Nicotinamide Riboside Supplements Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Nicotinamide Riboside Supplements Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Nicotinamide Riboside Supplements Sales Quantity by Type (2018-2029)
  • 5.2 Global Nicotinamide Riboside Supplements Consumption Value by Type (2018-2029)
  • 5.3 Global Nicotinamide Riboside Supplements Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Nicotinamide Riboside Supplements Sales Quantity by Application (2018-2029)
  • 6.2 Global Nicotinamide Riboside Supplements Consumption Value by Application (2018-2029)
  • 6.3 Global Nicotinamide Riboside Supplements Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Nicotinamide Riboside Supplements Sales Quantity by Type (2018-2029)
  • 7.2 North America Nicotinamide Riboside Supplements Sales Quantity by Application (2018-2029)
  • 7.3 North America Nicotinamide Riboside Supplements Market Size by Country
    • 7.3.1 North America Nicotinamide Riboside Supplements Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Nicotinamide Riboside Supplements Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Nicotinamide Riboside Supplements Sales Quantity by Type (2018-2029)
  • 8.2 Europe Nicotinamide Riboside Supplements Sales Quantity by Application (2018-2029)
  • 8.3 Europe Nicotinamide Riboside Supplements Market Size by Country
    • 8.3.1 Europe Nicotinamide Riboside Supplements Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Nicotinamide Riboside Supplements Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nicotinamide Riboside Supplements Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Nicotinamide Riboside Supplements Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Nicotinamide Riboside Supplements Market Size by Region
    • 9.3.1 Asia-Pacific Nicotinamide Riboside Supplements Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Nicotinamide Riboside Supplements Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Nicotinamide Riboside Supplements Sales Quantity by Type (2018-2029)
  • 10.2 South America Nicotinamide Riboside Supplements Sales Quantity by Application (2018-2029)
  • 10.3 South America Nicotinamide Riboside Supplements Market Size by Country
    • 10.3.1 South America Nicotinamide Riboside Supplements Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Nicotinamide Riboside Supplements Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nicotinamide Riboside Supplements Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Nicotinamide Riboside Supplements Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Nicotinamide Riboside Supplements Market Size by Country
    • 11.3.1 Middle East & Africa Nicotinamide Riboside Supplements Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Nicotinamide Riboside Supplements Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Nicotinamide Riboside Supplements Market Drivers
  • 12.2 Nicotinamide Riboside Supplements Market Restraints
  • 12.3 Nicotinamide Riboside Supplements Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nicotinamide Riboside Supplements and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nicotinamide Riboside Supplements
  • 13.3 Nicotinamide Riboside Supplements Production Process
  • 13.4 Nicotinamide Riboside Supplements Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nicotinamide Riboside Supplements Typical Distributors
  • 14.3 Nicotinamide Riboside Supplements Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Nicotinamide Riboside Supplements. Industry analysis & Market Report on Nicotinamide Riboside Supplements is a syndicated market report, published as Global Nicotinamide Riboside Supplements Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Nicotinamide Riboside Supplements market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,358.20
    		5,037.30
    		6,716.40
    		547,160.40
    		820,740.60
    		1,094,320.80
    		298,270.80
    		447,406.20
    		596,541.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo